Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Other Non Operating Income (2016 - 2025)

Anaptysbio's Other Non Operating Income history spans 10 years, with the latest figure at -$3000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 114.29% year-over-year to -$3000.0; the TTM value through Dec 2025 reached $5.4 million, up 38685.71%, while the annual FY2025 figure was $5.4 million, 38685.71% up from the prior year.
  • Other Non Operating Income reached -$3000.0 in Q4 2025 per ANAB's latest filing, down from $3.5 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.5 million in Q2 2025 to a low of -$5000.0 in Q3 2024.
  • Average Other Non Operating Income over 5 years is $323000.0, with a median of $3000.0 recorded in 2021.
  • Peak YoY movement for Other Non Operating Income: crashed 600.0% in 2024, then skyrocketed 95200.0% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $1000.0 in 2021, then crashed by 500.0% to -$4000.0 in 2022, then soared by 50.0% to -$2000.0 in 2023, then surged by 1150.0% to $21000.0 in 2024, then plummeted by 114.29% to -$3000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Other Non Operating Income are -$3000.0 (Q4 2025), $3.5 million (Q2 2025), and $1.9 million (Q1 2025).